揭示急性和COVID后的细胞因子模式,以预测未来的挑战
Makhabbat Bekbossynova1, Ainur Tauekelova1, Aliya Sailybayeva1
1National Research Cardiac Surgery Center, Astana 020000, Kazakhstan.
Journal of clinical medicine
|August 26, 2023
概括
细胞因子档案揭示了COVID-19患者的免疫反应. 特定的细胞因子与疾病严重程度和COVID后并发症相关,为预后和向治疗提供潜在的生物标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 生物标志物 生物标志物
背景情况:
- COVID-19引发了复杂的免疫反应.
- 了解这些反应对于管理急性感染和长期后果至关重要.
- 细胞因子在病毒感染期间在免疫调节中发挥着关键作用.
研究的目的:
- 为了分析COVID-19患者的细胞因子概况.
- 为了将细胞因子水平与疾病严重程度和COVID后并发症相关联.
- 确定潜在的预后生物标志物和治疗点.
主要方法:
- 对细胞因子模式的多重分析.
- 该研究包括294名患有急性和COVID后疾病的患者.
- 在不同疾病严重程度的细胞因子水平的比较.
主要成果:
- 升高的IL-15,IL-8和与疾病严重程度相关的碎素.
- 严重的COVID-19与较高水平的MCP-1,IFNa2,IL-7,IL-15,EGF,IP-10,IL-8,Eotaxin,FGF-2,GROa,sCD40L和IL-10有关. 这种疾病的发病因子包括:
- 在COVID后的关键细胞因子包括FGF-2,VEGF-A,EGF,IL-12 (p70),IL-13和IL-6.
- 显著的细胞因子配置描述了COVID后的并发症,如高血压和糖尿病.
- 在感染的急性阶段可以预测并发症.
结论:
- 细胞因子分析提供了对COVID-19病原体的见解.
- 特定的细胞因子模式可以预测疾病严重程度和COVID后并发症.
- 识别这些生物标志物可以指导预后和治疗策略,以改善患者的治疗结果.
相关概念视频
COPD: Pathogenesis and Clinical Features
341
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
341
Asthma: Pathogenesis and Management
443
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
443
COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244
Pneumonia II: Pathophysiology
336
The pathophysiology of pneumonia involves the following steps:
336
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


